QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHL

NCT03169790 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Trial not initiated

Conditions

Non Hodgkin Lymphoma

Interventions

BIOLOGICAL: avelumab
BIOLOGICAL: bevacizumab
DRUG: capecitabine
DRUG: cyclophosphamide
DRUG: 5-Fluorouracil (5-FU)
DRUG: leucovorin
DRUG: nab-paclitaxel
DRUG: Lovaza
DRUG: Oxaliplatin
DRUG: rituximab
RADIATION: Stereotactic Body Radiation Therapy
BIOLOGICAL: ALT-803
BIOLOGICAL: ETBX-061
BIOLOGICAL: haNK

Sponsor

ImmunityBio, Inc.